Quantification of phenolic acid metabolites in humans by LC–MS: a structural and targeted metabolomics approach

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Wikoff WR, Anfora AT, Liu J et al. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc. Natl Acad. Sci. USA 106(10), 3698–3703 (2009). • Overview of gut microbiota effects on metabolites in blood.
  Medline CASGoogle Scholar
• 2 Collins SM, Surette M, Bercik P. The interplay between the intestinal microbiota and the brain. Nat. Rev. Microbiol. 10(11), 735–742 (2012). • Overview of gut microbiota-derived interactions with the brain.
  Medline CASGoogle Scholar
• 3 Obrenovich M, Fluckiger R, Sykes L, Donskey C. The co-metabolism within the gut–brain metabolic interaction: potential targets for drug treatment and design. CNS Neurol. Disord. Drug Targets 15(2), 127–134 (2016).
  Medline CASGoogle Scholar
• 4 Armstrong MD, Shaw KN. The occurrence of (-)-β-m-hydroxyphenyl-hydracrylic acid in human urine. J. Biol. Chem. 225(1), 269–278 (1957).
  Medline CASGoogle Scholar
• 5 Kesli R, Gokcen C, Bulug U, Terzi Y. Investigation of the relation between anaerobic bacteria genus clostridium and late-onset autism etiology in children. J. Immunoassay Immunochem. 35(1), 101–109 (2014).
  Medline CASGoogle Scholar
• 6 Shaw W. Increased urinary excretion of a 3-(3-hydroxyphenyl)-3-hydroxypropionic acid (HPHPA), an abnormal phenylalanine metabolite of Clostridia spp. in the gastrointestinal tract, in urine samples from patients with autism and schizophrenia. Nutr. Neurosci. 13(3), 135–143 (2010). •• Data linking urinary phenolic acid metabolites, intestinal anaerobes and mental illness.
  Medline CASGoogle Scholar
• 7 Bouatra S, Aziat F, Mandal R et al. The human urine metabolome. PLoS ONE 8(9), e73076 (2013).
  Medline CASGoogle Scholar
• 8 Fang ZZ, Gonzalez FJ. LC–MS-based metabolomics: an update. Arch. Toxicol. 88(8), 1491–1502 (2014).
  Medline CASGoogle Scholar
• 9 Williamson G, Clifford MN. Role of the small intestine, colon and microbiota in determining the metabolic fate of polyphenols. Biochem. Pharmacol. 139, 24–39 (2017). • Overview of intestinal microbiota-mediated metabolism of polyphenols.
  Medline CASGoogle Scholar
• 10 Shangari N, Chan TS, O'brien PJ. Sulfation and glucuronidation of phenols: implications in coenyzme Q metabolism. Methods Enzymol. 400, 342–359 (2005).
  Medline CASGoogle Scholar
• 11 Von Studnitz W, Engelman K, Sjoerdsma A. Urinary excretion of phenolic acids in human subjects on a glucose diet. Clin. Chim. Acta 9, 224–227 (1964).
  Medline CASGoogle Scholar
• 12 Xiong X, Liu D, Wang Y, Zeng T, Peng Y. Urinary 3-(3-hydroxyphenyl)-3-hydroxypropionic acid, 3-hydroxyphenylacetic acid, and 3-hydroxyhippuric acid are elevated in children with autism spectrum disorders. Biomed. Res. Int. 2016 9485412 (2016). •• Data linking urinary phenolic acid metabolites, intestinal anaerobes and mental illness.
  MedlineGoogle Scholar
• 13 Curtius HC, Redweik U, Steinmann B, Leimbacher W, Wegmann H. Use of deuterated tyrosine and phenylalanine in the study of catecholamine and aromatic amino acid metabolism. In: Proceedings of the Second International Conference on Stable Isotopes, October 20-23, 1975. Oakbrook, IL. Klein ER, Klein PD (Eds). Energy Research and Development Administration, WA, DC, USA, 385–391 (1976).
  Google Scholar
• 14 Jaganath IB, Mullen W, Edwards CA, Crozier A. The relative contribution of the small and large intestine to the absorption and metabolism of rutin in man. Free Radic. Res. 40(10), 1035–1046 (2006).
  Medline CASGoogle Scholar
• 15 Olthof MR, Hollman PC, Buijsman MN, Van Amelsvoort JM, Katan MB. Chlorogenic acid, quercetin-3-rutinoside and black tea phenols are extensively metabolized in humans. J. Nutr. 133(6), 1806–1814 (2003).
  Medline CASGoogle Scholar
• 16 Liebich HM, Pickert A, Tetschner B. Gas chromatographic and gas chromatographic–mass spectrometric analysis of organic acids in plasma of patients with chronic renal failure. J. Chromatogr. 289, 259–266 (1984).
  Medline CASGoogle Scholar
• 17 Hicks JM, Young DS, Wootton ID. Abnormal blood constituents in acute renal failure. Clin. Chim. Acta 7, 623–633 (1962).
  Medline CASGoogle Scholar
• 18 Pereira-Caro G, Ludwig IA, Polyviou T et al. Identification of plasma and urinary metabolites and catabolites derived from orange juice (poly)phenols: analysis by high-performance liquid chromatography–high-resolution mass spectrometry. J. Agric. Food Chem. 64(28), 5724–5735 (2016).
  Medline CASGoogle Scholar
• 19 Tetko IV, Gasteiger J, Todeschini R et al. Virtual computational chemistry laboratory – design and description. J. Comput. Aided Mol. Des. 19(6), 453–463 (2005).
  Medline CASGoogle Scholar
• 20 Goudas LC, Langlade A, Serrie A et al. Acute decreases in cerebrospinal fluid glutathione levels after intracerebroventricular morphine for cancer pain. Anesth. Analg. 89(5), 1209–1215 (1999).
  Medline CASGoogle Scholar
• 21 Wang D, Ho L, Faith J et al. Role of intestinal microbiota in the generation of polyphenol-derived phenolic acid mediated attenuation of Alzheimer's disease β-amyloid oligomerization. Mol. Nutr. Food Res. 59(6), 1025–1040 (2015).
  Medline CASGoogle Scholar
• 22 Van De Merbel NC. Quantitative determination of endogenous compounds in biological samples using chromatographic techniques. Trends Anal. Chem. 27(10), 924–933 (2008).
  CASGoogle Scholar
• 23 Bernini P, Bertini I, Luchinat C, Nincheri P, Staderini S, Turano P. Standard operating procedures for pre-analytical handling of blood and urine for metabolomic studies and biobanks. J. Biomol. NMR 49(3–4), 231–243 (2011).
  Medline CASGoogle Scholar
• 24 Obrenovich ME, Tima M, Polinkovsky A, Zhang R, Emancipator SN, Donskey CJ. Targeted metabolomics analysis identifies intestinal microbiota-derived urinary biomarkers of colonization resistance in antibiotic-treated mice. Antimicrob. Agents Chemother. 61(8), e0047–17 (2017).
  Google Scholar
• 25 Wang Z, Levison BS, Hazen JE, Donahue L, Li XM, Hazen SL. Measurement of trimethylamine-N-oxide by stable isotope dilution liquid chromatography tandem mass spectrometry. Anal. Biochem. 455, 35–40 (2014).
  Medline CASGoogle Scholar
• 26 Horton A, Nash K, Tackie-Yarboi E et al. Furoxans (oxadiazole-4 N-oxides) with attenuated reactivity are neuroprotective, cross the blood–brain barrier, and improve passive avoidance memory. J. Med. Chem. 61(10), 4593–4607 (2018).
  Medline CASGoogle Scholar
• 27 Suh JW, Lee SH, Chung BC. GC–MS determination of organic acids with solvent extraction after cation-exchange chromatography. Clin. Chem. 43(12), 2256–2261 (1997).
  Medline CASGoogle Scholar
• 28 Porter RD, Cathcart-Rake WF, Wan SH, Whittier FC, Grantham JJ. Secretory activity and aryl acid content of serum, urine, and cerebrospinal fluid in normal and uremic man. J. Lab. Clin. Med. 85(5), 723–731 (1975).
  Medline CASGoogle Scholar
• 29 Young SN, Davis BA, Gauthier S. Precursors and metabolites of phenylethylamine, m and p-tyramine and tryptamine in human lumbar and cisternal cerebrospinal fluid. J. Neurol. Neurosurg. Psychiatry 45(7), 633–639 (1982).
  Medline CASGoogle Scholar
• 30 Kaddurah-Daouk R, Yuan P, Boyle SH et al. Cerebrospinal fluid metabolome in mood disorders-remission state has a unique metabolic profile. Sci. Rep. 2, 667 (2012).
  MedlineGoogle Scholar
• 31 Karoum F, Gillin JC, Wyatt RJ, Costa E. Mass-fragmentography of nanogram quantities of biogenic amine metabolites in human cerebrospinal fluid and whole rat brain. Biomed. Mass Spectrom. 2, 183–189 (1975).
  CASGoogle Scholar
• 32 Tohgi H, Takahashi S, Abe T. The effect of age on concentrations of monoamines, amino acids, and their related substances in the cerebrospinal fluid. J. Neural. Transm. Park. Dis. Dement. Sect. 5(3), 215–226 (1993).
  Medline CASGoogle Scholar
• 33 Wishart DS, Feunang YD, Marcu A et al. HMDB 4.0: the human metabolome database for 2018. Nucleic Acids Res. 46(D1), D608–D617 (2018).
  Medline CASGoogle Scholar
• 34 Joseph MH. Determination of kynurenine by a simple gas–liquid chromatographic method applicable to urine, plasma, brain and cerebrospinal fluid. J. Chromatogr. 146(1), 33–41 (1978).
  Medline CASGoogle Scholar
• 35 Yan EB, Frugier T, Lim CK et al. Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans. J. Neuroinflammation 12, 110 (2015).
  MedlineGoogle Scholar
• 36 Young SN, Anderson GM, Gauthier S, Purdy WC. The origin of indoleacetic acid and indolepropionic acid in rat and human cerebrospinal fluid. J. Neurochem. 34(5), 1087–1092 (1980).
  Medline CASGoogle Scholar
• 37 Bongiovanni R, Mchaourab AS, Mcclellan F, Elsworth J, Double M, Jaskiw GE. Large neutral amino acids levels in primate cerebrospinal fluid do not confirm competitive transport under baseline conditions. Brain Res. 1648(Pt A), 372–379 (2016).
  Medline CASGoogle Scholar
• 38 Huang Y, Tian Y, Zhang Z, Peng C. A HILIC-MS/MS method for the simultaneous determination of seven organic acids in rat urine as biomarkers of exposure to realgar. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 905, 37–42 (2012).
  Medline CASGoogle Scholar
• 39 Booth AN, Masri MS, Robbins DJ, Emerson OH, Jones FT, Deeds F. Urinary metabolites of coumarin and o-coumaric acid. J. Biol. Chem. 234(4), 946–948 (1959).
  Medline CASGoogle Scholar
• 40 Wadman SK, Van Der Heiden C, Ketting D, Kamerling JP, Vliegenthart JF. β-p-hydroxyphenylhydracrylic acid as a urinary constituent in a patient with gastrointestinal disease. Clin. Chim. Acta 47(2), 307–314 (1973).
  Medline CASGoogle Scholar
• 41 Rampini S, Vollmin JA, Bosshard HR, Muller M, Curtius HC. Aromatic acids in urine of healthy infants, persistent hyperphenylalaninemia, and phenylketonuria, before and after phenylalanine load. Pediatr. Res. 8(7), 704–709 (1974).
  Medline CASGoogle Scholar
• 42 Fernell E, Karagiannakis A, Edman G, Bjerkenstedt L, Wiesel FA, Venizelos N. Aberrant amino acid transport in fibroblasts from children with autism. Neurosci. Lett. 418(1), 82–86 (2007).
  Medline CASGoogle Scholar
• 43 Bongiovanni R, Leonard S, Jaskiw GE. A simplified method to quantify dysregulated tyrosine transport in schizophrenia. Schizophr. Res. 150(2–3), 386–391 (2013).
  MedlineGoogle Scholar
• 44 Obrenovich ME, Li Y, Parvathaneni K et al. Antioxidants in health, disease and aging. CNS Neurol. Disord. Drug Targets 10(2), 192–207 (2011).
  Medline CASGoogle Scholar
• 45 Wang J, Hodes GE, Zhang H et al. Epigenetic modulation of inflammation and synaptic plasticity promotes resilience against stress in mice. Nat. Commun. 9(1), 477 (2018).
  MedlineGoogle Scholar
• 46 Sherwin E, Dinan TG, Cryan JF. Recent developments in understanding the role of the gut microbiota in brain health and disease. Ann. N. Y. Acad. Sci. 1420(1), 5–20 (2017).
  MedlineGoogle Scholar
• 47 Mazzoli R, Pessione E. The neuro-endocrinological role of microbial glutamate and GABA signaling. Front. Microbiol. 7, 1934 (2016).
  MedlineGoogle Scholar
• 48 Obrenovich M, Mana TSC, Rai H et al. Recent findings within the microbiota–gut–brain–endocrine metabolic interactome. Pathol. Lab. Med. Int. 9, 21–30 (2017).
  Google Scholar